Details of the Drug Reposition

General Information of This Drug (ID: DMBPJ9U)

Drug Name
PEGylated pitrakinra   DMBPJ9U
Synonyms
Aeroderm; Dermalast; AER-003; PEGylated pitrakinra (subcutaneous, eczema/allergy), Aerovance; PEGylated AER-001 (subcutaneous, eczema/allergy), Aerovance; PEGylated IL-4 variant (subcutaneous, eczema/allergy), Aerovance
Drug Type
Monoclonal antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Asthma DISW9QNS CA23 Phase 2 [1]
------------------------------------------------------------------------------------
1 Investigative Indication(s)
Indication Name Indication ID ICD-11 Status REF
Allergy DIS48ZAP 4A80-4A85 Investigative [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT00801853) A Study of the Treatment-Sparing Effects of AEROVANT AER 001 Inhalation Powder in Asthma Patients, AEROTRIAL
2 The potential of biologics for the treatment of asthma. Nat Rev Drug Discov. 2012 Dec;11(12):958-72.